HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ebrahim S Delpassand Selected Research

pentetreotide (OctreoScan)

1/2014The value of (68)Ga-DOTATATE PET/CT in diagnosis and management of neuroendocrine tumors compared to current FDA approved imaging modalities: a review of literature.
1/2012Long-Term Survival, Toxicity Profile, and role of F-18 FDG PET/CT scan in Patients with Progressive Neuroendocrine Tumors Following Peptide Receptor Radionuclide Therapy with High Activity In-111 Pentetreotide.
6/2008Safety and efficacy of radionuclide therapy with high-activity In-111 pentetreotide in patients with progressive neuroendocrine tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ebrahim S Delpassand Research Topics

Disease

10Neuroendocrine Tumors (Neuroendocrine Tumor)
01/2022 - 06/2008
8Neoplasms (Cancer)
01/2022 - 11/2003
3Prostatic Neoplasms (Prostate Cancer)
01/2022 - 01/2020
3Neoplasm Metastasis (Metastasis)
01/2020 - 06/2003
2Uterine Cervical Neoplasms (Cancer of the Cervix)
11/2003 - 02/2002
1Cardiotoxicity
01/2018
1Atherosclerotic Plaque (Atheroma)
01/2015
1Rupture
01/2015
1Breast Neoplasms (Breast Cancer)
01/2005
1Non-Hodgkin Lymphoma (Lymphosarcoma)
04/2004
1Lymphatic Metastasis
11/2003
1Leiomyoma (Uterine Fibroids)
11/2003
1Carcinoma (Carcinomatosis)
06/2003
1Primary Hyperparathyroidism
12/2002

Drug/Important Bio-Agent (IBA)

12Radioisotopes (Radionuclides)IBA
01/2021 - 04/2004
8Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
01/2022 - 01/2012
8Peptide Receptors (Peptide Receptor)IBA
01/2022 - 01/2012
5Somatostatin Receptors (Somatostatin Receptor)IBA
01/2020 - 01/2012
3lutetium Lu 177 dotatateIBA
01/2022 - 05/2014
3pentetreotide (OctreoScan)FDA Link
01/2014 - 06/2008
2AntigensIBA
01/2021 - 01/2020
1gallium 68 PSMA-11IBA
01/2022
1Lutetium-177IBA
01/2021
164Cu-DOTATATEIBA
01/2020
1RadiopharmaceuticalsIBA
01/2020
1Prostate-Specific Antigen (Semenogelase)IBA
01/2020
1Octreotide (Sandostatin)FDA LinkGeneric
01/2019
1Pharmaceutical PreparationsIBA
01/2019
1177Lu-octreotateIBA
06/2017
1LutetiumIBA
06/2017
1somatostatin receptor 2IBA
01/2015
13-Iodobenzylguanidine (Iobenguane)IBA
01/2014
1Technetium Tc 99m Sulfur ColloidFDA Link
01/2005
1AntibodiesIBA
04/2004
1tositumomab I-131 (Bexxar)FDA Link
04/2004
1ibritumomab tiuxetan (Zevalin)FDA Link
04/2004
1IsotopesIBA
04/2004
1FluorineIBA
11/2003
1Deoxyglucose (2 Deoxy D glucose)IBA
11/2003
1Contrast MediaIBA
11/2003
1AndrogensIBA
06/2003
1Strontium-89IBA
06/2003
1GemcitabineFDA Link
06/2003

Therapy/Procedure

12Therapeutics
01/2022 - 04/2004
2Castration
01/2021 - 01/2020
2Drug Therapy (Chemotherapy)
01/2021 - 04/2004
2Lymph Node Excision (Lymph Node Dissection)
01/2005 - 02/2002
1Radiotherapy
01/2022
1Parathyroidectomy
12/2002
1Hysterectomy
02/2002